Colorectal Unit, Department of Surgery, Västmanland Hospital Västerås, 72189, Västerås, Sweden.
Colorectal Unit, Department of Surgery, Centre for Clinical Research of Uppsala University, Västmanland Hospital Västerås, Västerås, Sweden.
J Robot Surg. 2023 Aug;17(4):1715-1720. doi: 10.1007/s11701-023-01571-5. Epub 2023 Mar 28.
Robotic low anterior resection (R-LAR) for rectal cancer may decrease estimated blood loss compared with open low anterior resection (O-LAR). The aim of this study was to compare estimated blood loss and blood transfusion within 30 days after O-LAR and R-LAR. This was a retrospective matched cohort study based on prospectively registered data from Västmanland Hospital, Sweden. The first 52 patients operated on using R-LAR for rectal cancer at Västmanland Hospital were propensity score-matched 1:2 with patients who underwent O-LAR for age, sex, ASA (American Society of Anesthesiology physical classification system), and tumor distance from the anal verge. In total, 52 patients in the R-LAR group and 104 patients in the O-LAR group were included. Estimated blood loss was significantly higher in the O-LAR group compared with R-LAR: 582.7 ml (SD ± 489.2) vs. 86.1 ml (SD ± 67.7); p < 0.001. Within 30 days after surgery, 43.3% of patients who received O-LAR and 11.5% who received R-LAR were treated with blood transfusion (p < 0.001). As a secondary post hoc finding, multivariable analysis identified O-LAR and lower pre-operative hemoglobin level as risk factors for the need of blood transfusion within 30 days after surgery. Patients who underwent R-LAR had significantly lower estimated blood loss and a need for peri- and post-operative blood transfusion compared with O-LAR. Open surgery was shown to be associated with an increased need for blood transfusion within 30 days after low anterior resection for rectal cancer.
机器人辅助低位前切除术(R-LAR)治疗直肠癌可能会比开腹低位前切除术(O-LAR)减少估计失血量。本研究旨在比较 O-LAR 和 R-LAR 术后 30 天内的估计失血量和输血情况。这是一项基于瑞典韦斯特曼兰医院前瞻性注册数据的回顾性匹配队列研究。在韦斯特曼兰医院,前 52 例接受 R-LAR 治疗直肠癌的患者根据年龄、性别、ASA(美国麻醉医师协会身体状况分类系统)和肿瘤距肛门缘的距离与接受 O-LAR 治疗的患者进行了倾向评分匹配 1:2。共有 52 例 R-LAR 组和 104 例 O-LAR 组患者纳入研究。O-LAR 组的估计失血量明显高于 R-LAR 组:582.7ml(SD±489.2)比 86.1ml(SD±67.7);p<0.001。术后 30 天内,接受 O-LAR 的患者中有 43.3%和接受 R-LAR 的患者中有 11.5%需要输血(p<0.001)。作为事后的次要发现,多变量分析确定 O-LAR 和术前较低的血红蛋白水平是术后 30 天内需要输血的危险因素。与 O-LAR 相比,接受 R-LAR 的患者估计失血量明显减少,围手术期和术后输血的需求也明显减少。与低位前切除治疗直肠癌相关的 O-LAR 显示术后 30 天内输血需求增加。